May 11, 2011
Dr. Parkash Gill today announced that Veglin is not available until receiving further FDA approval. This delay is considered normal and a required process by the FDA. Once the FDA aproves, Alimta Cisplatin chemotherapy along with Veglin (a non-chemotherapy) will be the next protocol used.
For questions related to the foundation and to make contributions please contact:
(800) 909-Meso (6376)
3011 Townsgate Rd, Suite 450
Westlake Village, CA 91361
For more information and other questions contact:
©2016 Mesothelioma Research Foundation Of America